Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes

References

• Baldwin SL, Ching LK, Pine SO, Moutaftsi M, Lucas E, Vallur A, et al. 2013. Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8 + T cells. J Immunol. 191:2514–2525.
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Garg T, Murthy RS, Rath G, Goyal AK. 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 1–12.
   Web of Science ®Google Scholar
• Chol C, Guy C, Jacquet A, Castot-Villepelet A, Kreft-Jais C, Cambazard F, et al. 2013. Complications of BCG vaccine SSI® recent story and risk management plan: the French experience. Pharmacoepidemiol Drug Saf. 22:359–364.
   PubMed Web of Science ®Google Scholar
• Collins SL, Chan-Li Y, Hallowell RW, Powell JD, Horton MR. 2012. Pulmonary vaccination as a novel treatment for lung fibrosis. PLoS One. 7:e31299.
   PubMed Web of Science ®Google Scholar
• Cruz-Bustos T, Gonzalez-Gonzalez G, Morales-Sanfrutos J, Megia-Fernandez A, Santoyo-Gonzalez F, Osuna A. 2012. Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy. Int J Nanomed. 7:5941–5956.
   PubMed Web of Science ®Google Scholar
• Gagandeep Garg T., Malik B, Rath G, Goyal AK. 2014. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
   PubMed Web of Science ®Google Scholar
• Garg T. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. 2012. Iontophoresis: Drug delivery system by applying an electrical potential across the skin. Drug Deliv Lette. 2:270–280.
   Google Scholar
• Garg T, Goyal AK. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. 2014b. Liposomes: Targeted and controlled delivery system. Drug Deliv Lett. 4:62–71.
   Google Scholar
• Garg T, Goyal AK, Arora S, Murthy R. 2012a. Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of Type-2 diabetes mellitus. Drug Deliv Lett. 2:251–261.
   Google Scholar
• Garg T, Rath G, Goyal AK. 2014. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst. 31:331–364.
   PubMed Web of Science ®Google Scholar
• Garg T, Singh O, Arora S, Murthy R. 2012b. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
   PubMed Web of Science ®Google Scholar
• Goyal AK, Rath G, Garg T. 2013a. Nanotechnological approaches for genetic immunization. In: Erdmann VA & Barciszewski J, Eds. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases Berlin: Springer, pp. 67–120.
   Google Scholar
• Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
   PubMed Web of Science ®Google Scholar
• Granfors K. 1979. Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease. J Clin Microbiol. 9:336–341.
   PubMed Web of Science ®Google Scholar
• Kaur M, Garg T, Rath G, Goyal AK. 2014a. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31:49–88.
   PubMed Web of Science ®Google Scholar
• Kaur M, Malik B, Garg T, Rath G, Goyal AK. 2014b. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Das Gupta U., Gupta P, Rath G, Goyal AK. 2014c. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1–6.
   PubMed Web of Science ®Google Scholar
• Kirby DJ, Rosenkrands I, Agger EM, Andersen P, Coombes AG, Perrie Y. 2008. PLGA microspheres for the delivery of a novel subunit TB vaccine. J Drug Target. 16:282–293.
   PubMed Web of Science ®Google Scholar
• Ko YT, Bickel U. 2012. Liposome-encapsulated polyethylenimine/ oligonucleotide polyplexes prepared by reverse-phase evaporation technique. AAPS PharmSciTech. 13:373–378.
   PubMed Web of Science ®Google Scholar
• Modgill V, Garg T, Goyal AK, Rath G. 2014. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. 1–6.
   PubMed Web of Science ®Google Scholar
• Morie A, Garg T, Goyal AK, Rath G. 2014. Nanofibers as novel drug carrier – An overview. Artif Cells Nanomed Biotechnol. 1–9.
   PubMed Web of Science ®Google Scholar
• Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T, Yoshikawa M. 2000. Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol Chem. 381:67–74.
   PubMed Web of Science ®Google Scholar
• Orme IM. 2013. Vaccine development for tuberculosis: current progress. Drugs. 73:1015–1024.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, Goyal AK. 2013. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol.
   PubMed Web of Science ®Google Scholar
• Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G. 2014. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
   Web of Science ®Google Scholar
• Sylvester PW. 2011. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol. 716:157–168.
   PubMedGoogle Scholar
• Tang X, Deng W, Xie J. 2012. Novel insights into Mycobacterium antigen Ag85 biology and implications in countermeasures for M. tuberculosis. Crit Rev Eukaryot Gene Expr. 22:179–187.
   PubMed Web of Science ®Google Scholar